Inflammation and cancer revisited: An hypothesis on the oncogenic potential of the apoptotic tumor cell, Autoimmunity, vol.65, issue.24, pp.312-316, 2013. ,
DOI : 10.1158/0008-5472.CAN-05-2718
Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues, The Journal of Pathology, vol.465, issue.2, pp.177-194, 2011. ,
DOI : 10.1038/nature09141
Calreticulin exposure is required for the immunogenicity of ??-irradiation and UVC light-induced apoptosis, Cell Death and Differentiation, vol.59, issue.10, pp.1848-1850, 2007. ,
DOI : 10.1016/S0022-1759(02)00069-8
Calreticulin exposure dictates the immunogenicity of cancer cell death, Nature Medicine, vol.279, issue.1, pp.54-61, 2007. ,
DOI : 10.1038/nm1523
URL : https://hal.archives-ouvertes.fr/inserm-00451702
ERP57 Membrane Translocation Dictates the Immunogenicity of Tumor Cell Death by Controlling the Membrane Translocation of Calreticulin, The Journal of Immunology, vol.181, issue.4, pp.2533-2543, 2008. ,
DOI : 10.4049/jimmunol.181.4.2533
Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides, Molecular Cancer Therapeutics, vol.8, issue.9, pp.2693-2707, 2009. ,
DOI : 10.1158/1535-7163.MCT-09-0228
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1?????dependent adaptive immunity against tumors, Nature Medicine, vol.7, issue.10, pp.1170-1178, 2009. ,
DOI : 10.4049/jimmunol.172.6.3399
URL : https://hal.archives-ouvertes.fr/hal-00419823
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy, Immunological Reviews, vol.10, issue.1, pp.47-59, 2007. ,
DOI : 10.1016/j.jim.2004.03.013
Toll-like receptor 4???dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nature Medicine, vol.289, issue.9, pp.1050-1059, 2007. ,
DOI : 10.4049/jimmunol.173.1.307
URL : https://hal.archives-ouvertes.fr/hal-00316924
Role of Local Radiation Therapy in Cancer Immunotherapy, JAMA Oncology, vol.1, issue.9, pp.1325-1332, 2015. ,
DOI : 10.1001/jamaoncol.2015.2756
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy, Cancer Cell, vol.24, issue.5, pp.589-602 ,
DOI : 10.1016/j.ccr.2013.09.014
URL : http://doi.org/10.1016/j.ccr.2013.09.014
Combination Effect of Regulatory T-Cell Depletion and Ionizing Radiation in Mouse Models of Lung and Colon Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.92, issue.2, pp.390-398, 2015. ,
DOI : 10.1016/j.ijrobp.2015.01.011
Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma, Cancer Research, vol.72, issue.16, pp.3967-3976, 2012. ,
DOI : 10.1158/0008-5472.CAN-12-0851
URL : http://cancerres.aacrjournals.org/content/canres/72/16/3967.full.pdf
Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis, Gut, vol.43, issue.4, pp.575-577, 1998. ,
DOI : 10.1136/gut.43.4.575
Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report, Journal of Medical Case Reports, vol.15, issue.17, p.111, 2011. ,
DOI : 10.1158/1078-0432.CCR-09-0265
Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma, Acta Oncologica, vol.58, issue.3, pp.493-497, 2006. ,
DOI : 10.1016/j.ijrobp.2003.09.012
Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas, International Journal of Radiation Oncology*Biology*Physics, vol.2, issue.1-2, pp.141-147, 1977. ,
DOI : 10.1016/0360-3016(77)90020-7
An interesting case of possible abscopal effect in malignant melanoma, The British Journal of Radiology, vol.48, issue.574, pp.863-866, 1975. ,
DOI : 10.1259/0007-1285-48-574-863
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma, New England Journal of Medicine, vol.366, issue.10, pp.925-931, 2012. ,
DOI : 10.1056/NEJMoa1112824
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial, The Lancet Oncology, vol.16, issue.7, pp.795-803, 2015. ,
DOI : 10.1016/S1470-2045(15)00054-6
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy, OncoImmunology, vol.23, issue.5, p.28780, 2014. ,
DOI : 10.1158/1078-0432.CCR-09-1624
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody, Clinical Cancer Research, vol.15, issue.17, pp.5379-5388, 2009. ,
DOI : 10.1158/1078-0432.CCR-09-0265
URL : http://clincancerres.aacrjournals.org/content/clincanres/15/17/5379.full.pdf
Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice, International Journal of Oncology, vol.31, issue.3, pp.509-515, 2007. ,
DOI : 10.3892/ijo.31.3.509
Enhancement of Antitumor Radiation Efficacy and Consistent Induction of the Abscopal Effect in Mice by ECI301, an Active Variant of Macrophage Inflammatory Protein-1??, Clinical Cancer Research, vol.14, issue.4, pp.1159-1166, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-4485
Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy, Cancer Research, vol.70, issue.7, pp.2697-2706, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-2982
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated, International Journal of Radiation Oncology*Biology*Physics, vol.58, issue.3, pp.862-870, 2004. ,
DOI : 10.1016/j.ijrobp.2003.09.012
Irradiation and anti???PD-L1 treatment synergistically promote antitumor immunity in mice, Journal of Clinical Investigation, vol.124, issue.2, pp.687-695, 2014. ,
DOI : 10.1172/JCI67313DS1
URL : http://www.jci.org/articles/view/67313/files/pdf
Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas, International Journal of Radiation Oncology*Biology*Physics, vol.86, issue.2, pp.343-349, 2013. ,
DOI : 10.1016/j.ijrobp.2012.12.025
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963403
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer, Nature, vol.67, issue.7547, pp.373-377, 2015. ,
DOI : 10.1007/s00285-012-0589-7
Treatment of 4T1 Metastatic Breast Cancer with Combined Hypofractionated Irradiation and Autologous T-Cell Infusion, Radiation Research, vol.182, issue.2, pp.163-169, 2014. ,
DOI : 10.1667/RR13471.1
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma, New England Journal of Medicine, vol.363, issue.8, pp.711-723, 2010. ,
DOI : 10.1056/NEJMoa1003466
Safety, Activity, and Immune Correlates of Anti???PD-1 Antibody in Cancer, Sznol M (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, pp.2443-2454 ,
DOI : 10.1056/NEJMoa1200690
Safety and Activity of Anti???PD-L1 Antibody in Patients with Advanced Cancer, New England Journal of Medicine, vol.366, issue.26, pp.2455-2465, 2012. ,
DOI : 10.1056/NEJMoa1200694
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma, New England Journal of Medicine, vol.372, issue.21, pp.2006-2017, 2015. ,
DOI : 10.1056/NEJMoa1414428
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study, The Lancet Oncology, vol.18, issue.1, pp.31-41, 2017. ,
DOI : 10.1016/S1470-2045(16)30624-6
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial, The Lancet Oncology, vol.17, issue.7, pp.883-895, 2016. ,
DOI : 10.1016/S1470-2045(16)30098-5
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study, The Lancet Oncology, vol.17, issue.3, pp.299-308, 2016. ,
DOI : 10.1016/S1470-2045(15)00544-6
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer, New England Journal of Medicine, vol.363, issue.5, pp.411-422, 2010. ,
DOI : 10.1056/NEJMoa1001294
Immunosuppressive Strategies that are Mediated by Tumor Cells, Annual Review of Immunology, vol.25, issue.1, pp.267-296, 2007. ,
DOI : 10.1146/annurev.immunol.25.022106.141609
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895922
Interleukin-12 in anti-tumor immunity and immunotherapy, Cytokine & Growth Factor Reviews, vol.13, issue.2, pp.155-168, 2002. ,
DOI : 10.1016/S1359-6101(01)00032-6
Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma, BMC Cancer, vol.46, issue.1, p.38, 2013. ,
DOI : 10.2478/v10019-012-0035-x
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell???mediated glioma rejection, The Journal of Experimental Medicine, vol.90, issue.13, pp.2803-2811, 2013. ,
DOI : 10.1158/0008-5472.CAN-05-1682
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma, J Clin Oncol, vol.26, issue.36, pp.5896-5903, 2008. ,
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer, Cancer Immunology, Immunotherapy, vol.34, issue.1, pp.1315-1327, 2015. ,
DOI : 10.1007/s10439-005-9076-2
A phase I open-label study of Ad-RTS-hIL-12, an adenoviral vector engineered to express hIL-12 under the control of an oral activator ligand, in subjects with unresectable stage III/IV melanoma, ASCO Annual Meeting Abstracts, 2013. ,
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study, Cancer Immunology, Immunotherapy, vol.15, issue.23, pp.999-1009, 2015. ,
DOI : 10.1158/1078-0432.CCR-09-1624
Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours, Veterinary and Comparative Oncology, vol.62, issue.2, 2016. ,
DOI : 10.1111/j.1476-5829.2011.00301.x
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice, Journal of Clinical Investigation, vol.121, issue.10, pp.4015-4029, 2011. ,
DOI : 10.1172/JCI45862DS1